[go: up one dir, main page]

FI92058B - Förfarande för framställning av terapeutiskt verksamma 2-substituerade N,N'-ditrimetoxibensoylpiperaziner - Google Patents

Förfarande för framställning av terapeutiskt verksamma 2-substituerade N,N'-ditrimetoxibensoylpiperaziner Download PDF

Info

Publication number
FI92058B
FI92058B FI901883A FI901883A FI92058B FI 92058 B FI92058 B FI 92058B FI 901883 A FI901883 A FI 901883A FI 901883 A FI901883 A FI 901883A FI 92058 B FI92058 B FI 92058B
Authority
FI
Finland
Prior art keywords
substituted
nco
piperazine
preparation
ethanol
Prior art date
Application number
FI901883A
Other languages
English (en)
Finnish (fi)
Other versions
FI901883A0 (sv
FI92058C (sv
Inventor
Jean-Jacques Godfroid
Francoise Heymans
Pierre Braquet
Eduardo Pirotzky
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of FI901883A0 publication Critical patent/FI901883A0/sv
Publication of FI92058B publication Critical patent/FI92058B/sv
Application granted granted Critical
Publication of FI92058C publication Critical patent/FI92058C/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/192Radicals derived from carboxylic acids from aromatic carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI901883A 1989-04-15 1990-04-12 Förfarande för framställning av terapeutiskt verksamma 2-substituerade N,N'-ditrimetoxibensoylpiperaziner FI92058C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898908587A GB8908587D0 (en) 1989-04-15 1989-04-15 New 2-substituted n,n'-ditrimethoxybenzoyl piperazines
GB8908587 1989-04-15

Publications (3)

Publication Number Publication Date
FI901883A0 FI901883A0 (sv) 1990-04-12
FI92058B true FI92058B (sv) 1994-06-15
FI92058C FI92058C (sv) 1994-09-26

Family

ID=10655129

Family Applications (1)

Application Number Title Priority Date Filing Date
FI901883A FI92058C (sv) 1989-04-15 1990-04-12 Förfarande för framställning av terapeutiskt verksamma 2-substituerade N,N'-ditrimetoxibensoylpiperaziner

Country Status (32)

Country Link
US (1) US5019576A (sv)
JP (1) JP2633709B2 (sv)
KR (1) KR900016178A (sv)
AR (1) AR247736A1 (sv)
AT (1) AT399337B (sv)
AU (1) AU631334B2 (sv)
BE (1) BE1007245A3 (sv)
CA (1) CA2014521C (sv)
CH (1) CH681301A5 (sv)
DE (1) DE4011925A1 (sv)
DK (1) DK91890A (sv)
DZ (1) DZ1407A1 (sv)
ES (1) ES2019554A6 (sv)
FI (1) FI92058C (sv)
FR (2) FR2645859B1 (sv)
GB (2) GB8908587D0 (sv)
GR (1) GR1000355B (sv)
HK (1) HK95092A (sv)
IE (1) IE65058B1 (sv)
IN (1) IN175799B (sv)
IT (1) IT1241631B (sv)
LU (1) LU87719A1 (sv)
MA (1) MA21805A1 (sv)
NL (1) NL9000798A (sv)
NO (1) NO176098C (sv)
NZ (1) NZ233250A (sv)
OA (1) OA09446A (sv)
PT (1) PT93736B (sv)
SE (1) SE505186C2 (sv)
SG (1) SG92092G (sv)
TN (1) TNSN90051A1 (sv)
ZA (1) ZA902566B (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5344830A (en) * 1992-12-10 1994-09-06 Merck & Co., Inc. N,N-diacylpiperazine tachykinin antagonists
IL111730A (en) * 1993-11-29 1998-12-06 Fujisawa Pharmaceutical Co Piperazine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
US5883098A (en) * 1993-11-29 1999-03-16 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives
US5610165A (en) * 1994-02-17 1997-03-11 Merck & Co., Inc. N-acylpiperidine tachykinin antagonists
US5795894A (en) * 1995-05-02 1998-08-18 Schering Corporation Piperazino derivatives as neurokinn antagonists
CZ342397A3 (cs) * 1995-05-02 1998-03-18 Schering Corporation Piperazinové deriváty jako antagonisté neurokininu
BR9610277A (pt) * 1995-08-31 1999-07-06 Schering Corp Derivados de piperazino como antagonistas de neurowuinina
US5892039A (en) * 1995-08-31 1999-04-06 Schering Corporation Piperazino derivatives as neurokinin antagonists
US5869488A (en) * 1996-05-01 1999-02-09 Schering Corporation Piperazino derivatives as neurokinin antagonists
FR2780649B1 (fr) * 1998-07-06 2001-03-09 Univ Paris Vii Denis Diderot Derives de la piperazine pour l'inhibition de la replication du virus de l'immunodeficience humaine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1243991A (en) * 1968-06-10 1971-08-25 Ici Ltd Piperidine, morpholine and piperazine derivatives
FR2209560A1 (en) * 1972-12-07 1974-07-05 Degussa N-(Trialkoxyaroyl)-ethylenediamine derivs - useful as cardioactive medicaments, exhibit anti-ischaemic activity comparable to nitroglycerin
IL85700A0 (en) * 1987-03-24 1988-08-31 Takeda Chemical Industries Ltd 1,4-disubstituted piperazine compounds,their production and use
US4937246A (en) * 1987-11-25 1990-06-26 Takeda Chemical Industries, Ltd. PAF antagonist, 1,4-disubstituted piperazine compounds and production thereof
FI892468A (fi) * 1988-05-23 1989-11-24 Glaxo Group Ltd Piperazinderivat.
GB8823776D0 (en) * 1988-10-11 1988-11-16 Scras New 2-methoxycarbonyl sustituted n n'-di-(trimethoxybenzoyl)piperazines
GB8823775D0 (en) * 1988-10-11 1988-11-16 Scras New 2-carbonyl substituted n n'-di-(trimethoxybenzoyl)piperazines
US4997836A (en) * 1988-11-11 1991-03-05 Takeda Chemical Industries, Ltd. Trisubstituted piperazine compounds, their production and use

Also Published As

Publication number Publication date
JP2633709B2 (ja) 1997-07-23
FI901883A0 (sv) 1990-04-12
OA09446A (fr) 1992-10-15
GB2230262B (en) 1992-02-26
GR1000355B (el) 1992-06-25
AU5326190A (en) 1990-11-01
SE9001269L (sv) 1990-10-16
FR2645859A1 (fr) 1990-10-19
ATA86690A (de) 1994-09-15
FR2645859B1 (fr) 1992-06-05
PT93736A (pt) 1990-11-20
NL9000798A (nl) 1990-11-01
NZ233250A (en) 1991-03-26
CA2014521C (en) 1997-09-09
JPH02292266A (ja) 1990-12-03
SG92092G (en) 1992-12-04
IN175799B (sv) 1995-08-26
ZA902566B (en) 1991-01-30
IE65058B1 (en) 1995-10-04
GB8908587D0 (en) 1989-06-01
HK95092A (en) 1992-12-04
DZ1407A1 (fr) 2004-09-13
NO176098B (no) 1994-10-24
LU87719A1 (fr) 1990-07-24
GB9007612D0 (en) 1990-05-30
TNSN90051A1 (fr) 1991-03-05
AU631334B2 (en) 1992-11-19
ES2019554A6 (es) 1991-06-16
IT9020020A1 (it) 1991-10-12
NO901631D0 (no) 1990-04-10
AT399337B (de) 1995-04-25
DK91890A (da) 1990-10-16
FR2645743A1 (fr) 1990-10-19
IT9020020A0 (it) 1990-04-12
IE901314L (en) 1990-10-15
KR900016178A (ko) 1990-11-12
AR247736A1 (es) 1995-03-31
BE1007245A3 (fr) 1995-05-02
NO901631L (no) 1990-10-16
FI92058C (sv) 1994-09-26
PT93736B (pt) 1996-09-30
GR900100270A (en) 1991-09-27
CH681301A5 (sv) 1993-02-26
GB2230262A (en) 1990-10-17
FR2645743B1 (fr) 1992-06-05
CA2014521A1 (en) 1990-10-15
SE505186C2 (sv) 1997-07-14
NO176098C (no) 1995-02-01
DE4011925A1 (de) 1990-10-18
SE9001269D0 (sv) 1990-04-06
US5019576A (en) 1991-05-28
MA21805A1 (fr) 1990-12-31
IT1241631B (it) 1994-01-25
DK91890D0 (da) 1990-04-11

Similar Documents

Publication Publication Date Title
EP2562168B1 (en) Therapeutic piperazines as pde4 inhibitors
FI92058B (sv) Förfarande för framställning av terapeutiskt verksamma 2-substituerade N,N'-ditrimetoxibensoylpiperaziner
EP0873320A1 (en) Piperazine derivatives as tachykinin antagonists
BRPI0616581A2 (pt) composto, uso de um composto, formulação farmacêutica, e, processo para a preparação de um composto
MX2007015606A (es) Nuevos derivados de azetidina como antagonistas del receptor de neuroquinina para el tratamiento de enfermedades gastrointestinales.
KR20080089413A (ko) 카나비노이드 cb1 수용체 조절자로서의4,5-디하이드로-(1h)-피라졸 유도체
CA2781858C (en) Modulators of tnf-.alpha. signaling
WO2005080357A2 (fr) Derives d’oxazole, leur preparation et leur utilisation en therapeutique
Shin et al. α, β-Unsaturated Carboxylic Acid Derivatives. IV. General Synthesis of Unsaturated Unsymmetric 3, 6-Disubstituted-2, 5-piperazinediones
WO2005035488A2 (fr) Derives de thiophene-2-carboxamide et leurs utilisation comme antagonistes des recepteurs cb1 des cannabinoides
CA1320958C (en) 2-carbonyl substituted n,n'-di-(trimethoxybenzoyl) piperazines, process for preparing the same and therapeutical compounds containing them
CN101268043A (zh) 作为ccr3受体配体的氨基-烷基-酰胺衍生物
US4927825A (en) 2-methoxycarbonyl substituted N,N'-di-(trimethoxybenzoyl) piperazines, process for preparing the same and therapeutical compounds containing them
WO2009037244A2 (en) 5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists
Kovalenko et al. DRUG SYNTHESIS
FI65621C (fi) Foerfarande foer framstaellning av som cns-aktiva medel anvaendbara 2-(4,4-difluorfenyl-butyl)-6h-oktahydropyrazino-(1,2-c) pyrimidin-6-oner
Földényi et al. Heterozyklische Derivate von 2-Amino-4-nitrophenol
US4604466A (en) Piperidine-substituted pyrimidines

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: SOCIETE DE CONSEILS DE RECHERCHES ET D APPLICATION